News & Insight

25 July 2022
News
Discover: a year of scientific creativity 2022
Discover header 2021-22
Today we launch Discover: a year of scientific creativity – our annual progress magazine showcasing the power of global team science.  Discover celebrates how our community is coming together, thinking differently and driving progress …
Read the full article

Latest

Blog
25 July 2022
An atlas of oesophageal cancer development
From the team taking on our Cancer Causes challenge, a new integrated atlas of the stromal and epithelial interactions that drive cancers associated…
Blog
25 July 2022
An entirely new way to visualise tumours
Meet the global network of early-career researchers driving the development of cancer’s most intricate maps, as part of our 3D Tumour Mapping…
Blog
25 July 2022
Refuting the dogma surrounding breast cancer risk
Non-invasive breast carcinomas have long been assumed to be the precursors of any invasive cancers that follow. But new findings, from the team…
Blog
25 July 2022
Harnessing the microbiome to personalise colorectal cancer prevention, diagnosis and treatment
Colorectal cancer incidence is increasing worldwide, particularly in people younger than 50 years, but the reason remains a mystery. In addition, the…

Latest tweet

RT @ContraCancerEs: Un proyecto internacional para un desafío global. Se trata de la mayor iniciativa de financiación global fundada por @C… Mon Aug 15 11:04:35 +0000 2022

View on twitter

News and insight archive

Format
Choose
Team
Choose
Tags
Choose
Credit: Jeroen Claus (Phospho Biomedical Animation)
News
Metabolic fingerprinting reveals link between dietary fat restriction and therapy response
Research from the Cancer Grand Challenges Rosetta team has identified a potential metabolic weakness in cancer that could be amenable to treatment.   The findings, published in Cell, focused on exploring whether the…
29 October 2020
Bowel cancer cell, CRUK LRI Experimental Histopathology Unit
News
OPTIMISTICC: New connection drives poor outcomes in bowel cancer
Up to 45% of bowel cancers carry a fault in the KRAS gene, detrimentally affecting how a patient will respond to treatment. New results from the OPTIMISTICC team suggest these poor outcomes may be due to the way faulty…
20 October 2020
Lung cancer cell, full credit to LRI EM department.
News
Catalysing new thinking on the development of cancer
Some carcinogens can cause cancer without directly damaging DNA: a new study from the Cancer Grand Challenges Mutographs team challenges a long-held view on the early development of a tumour. For years, research has…
13 October 2020
Barbara Rimer and Jill P. Mesirov
People
New Scientific Committee members announced
The Cancer Grand Challenges Scientific Committee is pleased to welcome two new members: Professor Jill P Mesirov (University of California San Diego School of Medicine) and Professor Barbara K Rimer (University of North…
11 October 2020